Clinical Trial

Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study evaluate the efficacy and safety of benznidazole in the treatment of chronic indeterminate Chagas disease in children. All subjects will receive benznidazole and results will be compared to historically to a placebo arm.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-07-16; most recent amendment 2026-04-16.
Status change: Recruiting → Active, Not Recruiting 2023-08-08
Status change: Not Yet Recruiting → Recruiting 2020-07-29
Trial Details
NCT Number NCT04024163
Lead Sponsor Insud Pharma
Collaborators: Chemo Research
Conditions Chagas Disease
Enrollment 178 participants
Start Date 2019-09-19
Primary Completion 2027-08-30 (estimated)
Study Completion 2028-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-21